#Contraceptives Market growth

[tbrcresearchreport]

The Business Research Company offers contraceptives market research report 2023 with industry size, share, segments and market growth

[roseaa11]

Data Bridge Market Research analyses a growth rate in the hormonal contraceptive market in the forecast period 2023-2030. The expected CAGR of the hormonal contraceptive market tends to be around 4.60% in the mentioned forecast period. The market was valued at USD 16.6 billion in 2022 and would grow to USD 23.79 billion by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

[marketspace360]

Hormonal Contraceptives Market | Manufacturers, Regions, Type and Application, Forecast by 2029

[market-insider]

U.S. Contraceptive Market Showing Rapid Growth In Subdermal Implants Segments

The U.S. contraceptive market size is expected to reach USD 12.0 billion by 2030 registering a CAGR of 4.70%, according to a new report by Grand View Research, Inc. Improving access and awareness regarding Long-Acting Reversible Contraceptives (LARCs) and the effectiveness and convenience of using these products are expected to drive the growth of the industry. The Guttmacher Institute reported that 60% of women belonging to the reproductive age use contraception in the U.S. Use of hormonal contraceptives other than the birth control pill has significantly increased in married women.

Gain deeper insights on the market and receive your free copy with TOC now @: U.S. Contraceptive Market Report

The increasing availability of contraceptives in the U.S. has improved several aspects of society such as education, career opportunities, and poverty for women. Access to modern methods of contraception has significantly improved career opportunities and allowed women to earn wages at par with men. Moreover, it has also reduced the number of women living in poverty due to unintended pregnancies and the high costs associated with raising a child. The legalization of family planning in the majority of the states has reduced the economic burden for the next generation as there has been a substantial reduction in the number of citizens living in poverty as adults.

The onset of the COVID-19 pandemic has showcased a negative impact on the market partially offsetting the initiatives by manufacturers. Short-term contraceptives such as birth control pills and condoms require re-prescription filling and frequent purchase, which may increase the risk of exposure to the virus. Thus, usage of these products has been limited during the pandemic. Moreover, the availability and distribution of contraceptives at public healthcare centers have been impacted in the U.S. Unemployment and loss of insurance that covers expenses of contraceptives in the U.S. are also anticipated to limit usage during the COVID-19 pandemic.

[healthcarediagnosticmarket]

Progesterone Market Key Player Analysis: Growth Insights and Forecasts , Business Strategies, Challenges and Future Demand 2033

Global Progesterone Market Growth and Trends – Straits Research

Straits Research is pleased to present its comprehensive report on the global Progesterone Market, detailing market size, growth projections, trends, and key insights. With a projected CAGR of 12.3% from 2024 to 2032, the market is set to experience substantial growth, increasing from USD 1.50 billion in 2024 to USD 4.14 billion by 2032.

Market Definition:

Progesterone is a vital hormone, predominantly used in hormonal therapies. It plays a key role in regulating the menstrual cycle, supporting pregnancy, and managing conditions like dysfunctional uterine bleeding and endometrial cancer. There is a significant demand for progesterone in various medical treatments, driving its growing market share.

The global progesterone market is expected to grow rapidly due to increasing adoption of progesterone-based therapies for conditions such as menstrual irregularities, hormonal imbalances, contraception, and cancer therapies. This surge is also bolstered by the growing awareness of women's health and rising healthcare spending worldwide.

Market Size and Forecast

In 2023, the global progesterone market was valued at USD 1.34 billion. As the demand for progesterone-based treatments continues to rise, the market is projected to expand from USD 1.50 billion in 2024 to an estimated USD 4.14 billion by 2032. This growth will be driven by increasing healthcare expenditures, evolving consumer preferences for hormonal therapies, and expanding awareness around reproductive health.

Key Trends in the Progesterone Market:

Rise in Hormonal Therapy Awareness: The increasing awareness about the benefits of hormonal therapies, especially progesterone in regulating menstrual cycles and treating various gynecological disorders, is propelling the market's growth.

Technological Advancements in Drug Delivery Systems: Advances in the development of new drug delivery systems, such as injectable and oral progesterone formulations, are improving treatment outcomes and ensuring better patient compliance.

Growing Use in Contraceptive Treatments: The application of progesterone in contraception, particularly in the form of intrauterine devices (IUDs) and oral contraceptives, is significantly boosting market growth.

Growth Factors:

The progesterone market is witnessing substantial growth due to several driving factors:

Increasing Incidence of Hormonal Disorders: The rise in conditions like irregular menstrual cycles, menopause, and polycystic ovary syndrome (PCOS) is fueling the demand for progesterone-based treatments.

Expanding Healthcare Infrastructure in Emerging Economies: Improved access to healthcare, especially in regions like Asia-Pacific and Latin America, is driving the demand for progesterone therapies.

Aging Population and Increasing Healthcare Investments: With an aging global population and rising healthcare investments, the demand for progesterone, particularly in managing conditions related to reproductive health and endometrial cancer, is expected to rise.

Key Market Opportunities:

Unmet Needs in Fertility Treatments: There is a significant opportunity for the progesterone market to cater to the growing demand for fertility treatments, particularly in assisted reproductive technologies (ART) such as IVF.

Increasing Adoption of Bio-Similars: The adoption of bio-similar progesterone therapies, which offer cost-effective alternatives to branded treatments, presents significant growth opportunities for market players.

Research & Development in Personalized Medicine: Advancements in personalized medicine, tailored to specific hormonal needs, create opportunities for developing targeted progesterone therapies, thereby driving market expansion.

Market Segmentation:

The global progesterone market can be segmented as follows:

By Type:

<ol> <li>Natural Progesterone</li> <li>Synthetic Progesterone</li> </ol>

By Modes of Delivery Source:

<ol> <li>Injectable</li> <li>Suspended Form</li> <li>Oral</li> <li>Intravaginal</li> <li>Others</li> </ol>

By Application:

<ol> <li>Regulation of the Menstrual Cycle</li> <li>Dysfunctional Uterine Bleeding</li> <li>Endometrial Cancer</li> <li>Contraception</li> <li>Others</li> </ol>

For more detailed market segmentation, access the full report at this link.

Key Players in the Progesterone Market:

<ol> <li>Sofgen Pharmaceuticals</li> <li>Pfizer Inc.</li> <li>Cipla Limited</li> <li>Lupin</li> <li>Aquatic Remedies Pvt. Ltd.</li> <li>Wuhan Honor Bio-Pharm Co., Ltd</li> <li>Shanghai Yijing Industrial Co., Ltd.</li> <li>Estrellas Life Sciences Private Limited</li> <li>Intas Pharmaceuticals Ltd.</li> <li>AdvaCare Pharma</li> </ol>

Regional Insights:

Dominated Region: North America holds the largest share of the global progesterone market. The region's advanced healthcare infrastructure, higher demand for hormonal therapies, and extensive research and development activities have contributed to its dominance.

Fastest Growing Region: Europe is expected to be the fastest-growing market for progesterone due to an increasing awareness of reproductive health, an aging population, and the rising adoption of hormone-based treatments.

For More Information or Queries

To request more information, ask for customizations, or inquire about purchasing the full report, visit: this link.

Straits Research continues to provide insightful, data-driven research reports designed to help industry players, investors, and stakeholders make informed decisions. With our comprehensive analysis and projections, stakeholders can plan for future market developments and capitalize on emerging opportunities in the progesterone market.

About Straits Research:

Straits Research is a leading market research and consulting firm that provides in-depth analysis of global industries, delivering insights into market trends, forecasts, and strategic growth opportunities. With a robust team of experts and comprehensive data-driven reports, Straits Research helps clients gain a competitive edge and drive business growth.

Contact Us

Email: sales@straitsresearch.com

Address: 825 3rd Avenue, New York, NY, USA, 10022

Tel: UK: +44 203 695 0070, USA: +1 646 905 0080

[metatechinsights]

Pet Contraceptive Market Size & Forecast 2025-2035

Overview of the Pet Contraceptive Market

The global pet contraceptive market is projected to grow from USD 390.2 million in 2024 to USD 796.3 million by 2035, at a CAGR of 6.7% during the forecast period (2025–2035). Pet contraceptives, including drugs, devices, and non-invasive methods, are critical for controlling pet population growth, preventing unplanned litters, and promoting animal welfare. They are particularly valuable for pet owners, veterinary clinics, shelters, and animal hospitals in managing reproductive health ethically and efficiently.

For detailed insights, visit the full report here: [Pet Contraceptive Market Report] https://www.metatechinsights.com/industry-insights/pet-contraceptive-market-1159.

Key Market Dynamics

Rising Pet Ownership

The increasing trend of pet adoption globally has created a growing demand for pet contraceptives. Urbanization, improved disposable incomes, and lifestyle changes have led to more families adopting dogs and cats, which account for the largest share of pet contraceptives.

Overpopulation, particularly in regions with limited resources, has intensified the need for birth control to reduce stray animals and unplanned breeding.

Focus on Animal Welfare

Growing awareness about ethical pet care has driven demand for non-surgical contraceptive options, such as hormonal implants and injectable contraceptives. These methods are less invasive and minimize stress on animals compared to traditional sterilization surgeries.

Initiatives from governments and animal welfare organizations have further encouraged responsible pet ownership and population control measures.

Challenges in Adoption

The high cost of advanced contraceptive procedures remains a barrier. Veterinary services, including surgical sterilization and innovative contraceptive methods, are expensive and often inaccessible in low-income regions.

Lack of insurance coverage for pet contraceptive procedures further limits widespread adoption, particularly among middle-income households.

Innovative Non-Invasive Methods

Advances in veterinary medicine have introduced non-surgical contraceptives, including hormonal implants and immunocontraceptive vaccines. These alternatives are cost-effective, efficient, and preferred by pet owners for their minimal recovery time.

Regional Insights

North America leads the market, driven by high pet adoption rates, robust veterinary infrastructure, and increasing focus on animal rights.

Asia Pacific is the fastest-growing region due to urbanization, rising disposable incomes, and a growing pet population in countries like India and China.

Competitive Landscape

Key players such as Zoetis Inc., Pfizer, Merck Animal Health, and Virbac dominate the market. Emerging companies like Ark Sciences Inc. and Selmore Pharmaceuticals are also introducing niche products to meet evolving demands.

To explore in-depth market analysis, visit Pet Contraceptive Market Report.

[janetushar1]

Contraceptive Drugs Market to Hit $18.94 Billion by 2032

The global Contraceptive Drugs Market was valued at USD 6.31 Billion in 2024 and it is estimated to garner USD 18.94 Billion by 2032 with a registered CAGR of 5.2% during the forecast period 2024 to 2032.

Are you looking for the Contraceptive Drugs Market Research Report? You are at the right place. If you desire to find out more data about the report or want customization, Contact us. If you want any unique requirements, please allow us to customize and we will offer you the report as you want.

The global Contraceptive Drugs Market can be segmented on the basis of product type, Applications, distribution channel, market value, volume, and region [North America, Europe, Asia Pacific, Latin America, Middle East, and Africa]. The Contraceptive Drugs Industry 2024 report provides a comprehensive overview of critical elements of the industry including drivers, restraints, and management scenarios.

Download Sample PDF: @ https://www.vantagemarketresearch.com/contraceptive-drugs-market-1674/request-sample

Top Players

Agile Therapeutics, Allergan PLC, Bayer AG, GlaxoSmithKline PLC, Johnson & Johnson, Piramal Healthcare, Mylan N.V., Pfizer Inc., Novartis AG, Teva Pharmaceutical Industries Ltd. and others.

Trending 2024: Contraceptive Drugs Market Report Highlights:

A comprehensive assessment of the parent Industry

Development of key aspects of the business

A study of industry-wide market segments

Evaluation of market value and volume in past, present, and future years

Evaluation of market share

Tactical approaches of market leaders

Innovative strategies that help companies to improve their position in the market

You Can Buy This Report From Here: https://www.vantagemarketresearch.com/buy-now/contraceptive-drugs-market-1674/0

Analysis Of The Top Companies, Product Types, and Applications In The Market Report:

This report provides sales, revenue growth rate, and verified information about the major players. Also includes a regional analysis and a labor cost analysis, tables, and figures. It also highlights characteristics such as technological growth. The product type segment is expected to continue to maintain its leading position in the future and capture a significant market share based on sales. This report provides analysis, discussion, forecast, and debate on key industry trends, market share estimates, Industry size, and other information. This report also discusses drivers, risks, and opportunities.

Global Contraceptive Drugs Market report contains detailed data and analysis on the Contraceptive Drugs Market drivers, restraints, and opportunities. Experts with market and industry knowledge as well as research experience from regional experts validate the report. The Contraceptive Drugs Market report provides forecast, historical and current revenue for each industry, region, and end-user segment.

Regions Included

-North America [United States, Canada, Mexico]

-South America [Brazil, Argentina, Columbia, Chile, Peru]

-Europe [Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]

-Middle East & Africa [GCC, North Africa, South Africa]

-Asia-Pacific [China, Southeast Asia, India, Japan, Korea, Western Asia]

Global Contraceptive Drugs Market report data will help you make more informed decisions. For example, in relation to prices, distribution channels are means of marketing or identifying opportunities to introduce a new product or service. These results will also help you make more informed decisions about your existing operations and activities.

Read Full Research Report with [TOC] @ https://www.vantagemarketresearch.com/industry-report/contraceptive-drugs-market-1674

You Can Use The Contraceptive Drugs Market Report To Answer The Following Questions:

What are the growth prospects of the Contraceptive Drugs Market business?

Who are the key manufacturers in the Contraceptive Drugs Market space?

What Forecast Period for Global Contraceptive Drugs Industry Report?

What are the main segments of the global Contraceptive Drugs Market?

What are the key metrics like opportunities and market drivers?

The Contraceptive Drugs Market Insights

Product Development/Innovation: Detailed Information On Upcoming Technologies, R&D Activities, And Product Launches In The Market.

Competitive Assessment: In-Depth Assessment Of Market Strategies, Geographic And Business Segments Of Key Market Players.

Market Development: Comprehensive Information On Emerging Markets. This Report Analyzes The Market For Different Segments In Different Regions.

Market Diversification: Comprehensive Information On New Products, Untapped Regions, Latest Developments, And Investments In The Contraceptive Drugs Market.

Check Out More Reports

Global Proppants Market:  Report Forecast by 2032

Global Water Treatment Chemicals Market: Report Forecast by 2032

Global Food Coating Market: Report Forecast by 2032

Global Manual Call Point Market: Report Forecast by 2032

Global 3D Printing Ceramic Market: Report Forecast by 2032

[haggishlyhagging]

“Although the oppression of women is universal, feminist consciousness is not. While I am not sure that I could demonstrate the necessity of its appearance in this time and place and not in another, I believe it is possible to identify two features of current social reality which, if not sufficient, are at least necessary conditions for the emergence of feminist consciousness. These features constitute, in addition, much of the content of this consciousness. I refer, first, to the existence of what Marxists call ‘contradictions’ in our society and, second, to the presence, due to these same contradictions, of concrete circumstances which would permit a significant alteration in the status of women.

In Marxist theory, the stage is set for social change when existing forms of social interaction—property relations as well as values, attitudes, and beliefs—come into conflict with new social relations which are generated by changes in the mode of production:

At a certain stage of their development, the material forces of production in society come in conflict with the existing relations of production or—what is but a legal expression for the same thing—with the property relations within which they had been at work before. From forms of development of the forces of production these relations turn into their fetters. Then comes the period of social revolution.

Social conflict regularly takes an ideological form, so much so that conflicts which are fundamentally economic in origin may appear to be struggles between ideas, as, for instance, between competing conceptions of the nature of legitimate political authority or of woman's proper sphere. To date, no one has offered a comprehensive analysis of those changes in the socioeconomic stricture of contemporary American society which have made possible the emergence of feminist consciousness. This task is made doubly difficult by the fact that these changes constitute no completed process, no convenient object for dispassionate historical investigation, but are part of the fluid set of circumstances in which each of us must find our way from one day to another and whose ultimate direction is as yet unclear. In spite of this, several features of current social reality cannot escape notice.

First, if we add to the Marxist notion of ‘modes of production’ the idea of ‘modes of (biological) reproduction,’ then it is evident that the development of cheap and efficient types of contraception has been instrumental in changing both the concrete choices women are able to make and the prevailing conceptions about woman's function and destiny. Second, the rapid growth of service industries has had much to do with the steady rise in the percentage of women in the work force, since the post-World War II low in the early fifties. While poor women and women of color have often had to work for wages, middle-class women were largely restricted to the roles of wife, mother, and home maker; this restriction, together with the rationales that justify it, is clearly out of phase with the entry of millions of such women into the market economy. The growth and spread of a technology to ease the burden of housekeeping, a technology which is itself the result of a need on the part of late capitalism for ‘innovations’ in production, serves further to undermine traditional conceptions about woman's place. During part of the period of the most rapid rise in the percentage of women in the work force, to cite still another ‘contradiction,’ there appeared an anomalous and particularly virulent form of the ‘feminine mystique,’ which, together with its companion, the ideal of ‘togetherness,’ had the effect, among other things, of insuring that the family would remain an efficient vehicle of consumption. What triggered feminist consciousness most immediately, no doubt, were the civil rights movement and the peace and student movements of the sixties; while they had other aims as well, the later movements may also be read as expressions of protest against the growing bureaucratization, depersonalization, and inhumanity of late capitalist society. Women often found themselves forced to take subordinate positions within these movements; it did not take long for them to see the contradiction between the oppression these movements were fighting in the larger society and their own continuing oppression in the life of these movements themselves.”

-Sandra Lee Bartky, Femininity and Domination: Studies in the Phenomenology of Oppression